Seres Therapeutics
Biotechnology Research
Cambridge, Massachusetts, United States
172 employees
- Employees
- 172
- Contacts
- 3
- Emails
- 3
- Phones
- 2
Seres Therapeutics Overview
- Headquarters
- Cambridge, Massachusetts, United States
- Phone Number
- Available in AeroLeads
- Website
- serestherapeutics.com
- Industry
- Biotechnology Research
- Employees
- 172
- Founded
- 2010
- Funding
- 110.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Seres Therapeutics
Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWST™, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in medically compromised patients. We are also conducting research to inform further development of microbiome therapeutics for ulcerative colitis. For more information, please visit http://www.serestherapeutics.com/ .
Seres Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 2
- 50.0% coverage
Seres Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Georgia Giannopoulos | United States |
Email
Phone
|
|
| Spencer M. | Please Contact Me Directly at Smarks@origamisoftware.com | Greater Boston, United States |
Email
|
| Catherine (Cate) Fagan | Medford, Massachusetts, United States |
Email
Phone
|
|
| Matthew Henn | Executive VP, Chief Scientific Officer at Seres Therapeutics |
View
|
Employees by Management Level
Director
15 profiles
Individual contributor
11 profiles
Manager
10 profiles
Senior / Lead
9 profiles
Associate / junior
5 profiles
Executive
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 9 | 9 | 3 |
| Operations | 8 | 8 | 1 |
| Executive | 7 | 7 | 3 |
| Healthcare | 5 | 5 | 0 |
| IT | 3 | 3 | 1 |
| HR | 1 | 1 | 0 |
Seres Therapeutics Tech Stack
Engineering
2 profiles
Cloud / infrastructure
1 profile
Data / AI
1 profile
Compare Similar Companies to Seres Therapeutics
Vertex Pharmaceuticals
Biotechnology Research
Sarepta Therapeutics
Biotechnology Research
Beam Therapeutics
Biotechnology Research
Sage Therapeutics
Biotechnology Research
Intellia Therapeutics, Inc.
Biotechnology Research
Tessera Therapeutics
Biotechnology Research
Vedanta Biosciences, Inc.
Biotechnology Research
Spero Therapeutics
Biotechnology Research
Finch Therapeutics
Biotechnology Research
Kaleido Biosciences
Biotechnology Research